|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-8-21
|
|
pubmed:abstractText |
Information is limited as to how we should treat invasive anal squamous cell carcinoma (SCC) in patients with chronic immunosuppression, since the majority of clinical studies to date have excluded such patients. The objective of this study is to compare treatment outcomes in immunocompetent (IC) versus immunodeficient (ID) patients with invasive anal SCC treated similarly with combined modality therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1879-355X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
75
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
143-9
|
|
pubmed:meshHeading |
pubmed-meshheading:19203845-Adult,
pubmed-meshheading:19203845-Aged,
pubmed-meshheading:19203845-Aged, 80 and over,
pubmed-meshheading:19203845-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19203845-Anus Neoplasms,
pubmed-meshheading:19203845-CD4 Lymphocyte Count,
pubmed-meshheading:19203845-Carcinoma, Squamous Cell,
pubmed-meshheading:19203845-Colostomy,
pubmed-meshheading:19203845-Combined Modality Therapy,
pubmed-meshheading:19203845-Female,
pubmed-meshheading:19203845-Fluorouracil,
pubmed-meshheading:19203845-Follow-Up Studies,
pubmed-meshheading:19203845-HIV Seropositivity,
pubmed-meshheading:19203845-Humans,
pubmed-meshheading:19203845-Immunocompetence,
pubmed-meshheading:19203845-Immunocompromised Host,
pubmed-meshheading:19203845-Male,
pubmed-meshheading:19203845-Middle Aged,
pubmed-meshheading:19203845-Mitomycin,
pubmed-meshheading:19203845-Proportional Hazards Models,
pubmed-meshheading:19203845-Radiotherapy, Conformal,
pubmed-meshheading:19203845-Radiotherapy Dosage,
pubmed-meshheading:19203845-Survival Analysis,
pubmed-meshheading:19203845-Transplantation Immunology,
pubmed-meshheading:19203845-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
|
|
pubmed:affiliation |
Department of Radiation Oncology, University Hospitals Case Medical Center, Cleveland, OH, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Evaluation Studies
|
